These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 26313852)

  • 1. Treatment of inflammatory myopathy: emerging therapies and therapeutic targets.
    Moghadam-Kia S; Aggarwal R; Oddis CV
    Expert Rev Clin Immunol; 2015; 11(11):1265-75. PubMed ID: 26313852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myositis in clinical practice-relevance of new antibodies.
    Moghadam-Kia S; Aggarwal R; Oddis CV
    Best Pract Res Clin Rheumatol; 2018 Dec; 32(6):887-901. PubMed ID: 31427061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic advances in myositis.
    Aggarwal R; Oddis CV
    Curr Opin Rheumatol; 2012 Nov; 24(6):635-41. PubMed ID: 22955021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Update on the pharmacological treatment of adult myositis.
    Oddis CV
    J Intern Med; 2016 Jul; 280(1):63-74. PubMed ID: 27098592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modern Therapies for Idiopathic Inflammatory Myopathies (IIMs): Role of Biologics.
    Moghadam-Kia S; Oddis CV; Aggarwal R
    Clin Rev Allergy Immunol; 2017 Feb; 52(1):81-87. PubMed ID: 26767526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapeutic strategy in inflammatory myopathies (polymyositis, dermatomyositis, overlap myositis, and immune-mediated necrotizing myopathy)].
    Tournadre A
    Rev Med Interne; 2014 Jul; 35(7):466-71. PubMed ID: 24144868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcineurin inhibitors in a cohort of patients with antisynthetase-associated interstitial lung disease.
    Labirua-Iturburu A; Selva-O'Callaghan A; Martínez-Gómez X; Trallero-Araguás E; Labrador-Horrillo M; Vilardell-Tarrés M
    Clin Exp Rheumatol; 2013; 31(3):436-9. PubMed ID: 23465087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tacrolimus in idiopathic inflammatory myopathy-associated interstitial lung disease: defining roles and responders.
    Gordon P; Gooptu B
    Rheumatology (Oxford); 2015 Jan; 54(1):3-4. PubMed ID: 25342374
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of steroid-resistant polymyositis and dermatomyositis].
    Mimura T; Kanda H; Kubo K
    Nihon Rinsho; 2001 Oct; 59(10):2062-70. PubMed ID: 11676154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rituximab in the Treatment of Jo1 Antibody-associated Antisynthetase Syndrome: Anti-Ro52 Positivity as a Marker for Severity and Treatment Response.
    Bauhammer J; Blank N; Max R; Lorenz HM; Wagner U; Krause D; Fiehn C
    J Rheumatol; 2016 Aug; 43(8):1566-74. PubMed ID: 27252419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of idiopathic inflammatory myopathies.
    Amato AA; Griggs RC
    Curr Opin Neurol; 2003 Oct; 16(5):569-75. PubMed ID: 14501840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Favorable outcomes with tacrolimus in two patients with refractory interstitial lung disease associated with polymyositis/dermatomyositis.
    Ochi S; Nanki T; Takada K; Suzuki F; Komano Y; Kubota T; Miyasaka N
    Clin Exp Rheumatol; 2005; 23(5):707-10. PubMed ID: 16173253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myositis-associated Interstitial Lung Disease: Predictors of Failure of Conventional Treatment and Response to Tacrolimus in a US Cohort.
    Sharma N; Putman MS; Vij R; Strek ME; Dua A
    J Rheumatol; 2017 Nov; 44(11):1612-1618. PubMed ID: 28864644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in immunosuppressive therapy.
    Marder W; McCune WJ
    Semin Respir Crit Care Med; 2007 Aug; 28(4):398-417. PubMed ID: 17764058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Dermatomyositis and polymyositis: clinical aspects and treatment].
    Hachulla E
    Ann Med Interne (Paris); 2001 Nov; 152(7):455-64. PubMed ID: 11965087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antisynthetase syndrome: not just an inflammatory myopathy.
    Chatterjee S; Prayson R; Farver C
    Cleve Clin J Med; 2013 Oct; 80(10):655-66. PubMed ID: 24085811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous cyclophosphamide improves functional outcomes in interstitial lung disease related to idiopathic inflammatory myopathies.
    Moreno-Torres V; Martín-Iglesias D; Vivero F; González-Echavarri C; García-Moyano M; Enghelmayer JI; Malfante P; Gaser A; Ruiz-Irastorza G;
    Semin Arthritis Rheum; 2023 Apr; 59():152164. PubMed ID: 36773521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of inflammatory muscle disease in adults.
    Tournadre A; Dubost JJ; Soubrier M
    Joint Bone Spine; 2010 Oct; 77(5):390-4. PubMed ID: 20627789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunosuppressive drug therapy.
    McCune WJ; Vallance DK; Lynch JP
    Curr Opin Rheumatol; 1994 May; 6(3):262-72. PubMed ID: 8060760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclosporine treatment for polymyositis/dermatomyositis: is it possible to rescue the deteriorating cases with interstitial pneumonitis?
    Maeda K; Kimura R; Komuta K; Igarashi T
    Scand J Rheumatol; 1997; 26(1):24-9. PubMed ID: 9057798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.